indazoles has been researched along with Colitis in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Huang, J; Huang, S; Li, QJ; Long, H; Symonds, ALJ; Tang, X; Wan, YY; Wang, Z; Xu, L; Zhou, J; Zhu, B | 1 |
Gao, XJ; Liang, HH; Tang, B; Wei, ZG; Yi, L | 1 |
Crawford, K; Dusing, M; Frischer, JS; Knod, JL | 1 |
Basta, F; Bhatia, M; Bovi, G; de Joannon, AC; Guglielmotti, A; Landolfi, C; Ramnath, RD | 1 |
4 other study(ies) available for indazoles and Colitis
Article | Year |
---|---|
Targeting EZH2 histone methyltransferase activity alleviates experimental intestinal inflammation.
Topics: Animals; Cell Differentiation; Colitis; Colon; Colonic Neoplasms; Dextran Sulfate; Enhancer of Zeste Homolog 2 Protein; Enzyme Inhibitors; Female; Hematopoietic Stem Cells; Histone Code; Histones; In Vitro Techniques; Indazoles; Indoles; Inflammatory Bowel Diseases; Methylation; Mice; Myeloid-Derived Suppressor Cells; Pyridones | 2019 |
The protective effect of nigeglanine on dextran sulfate sodium-induced experimental colitis in mice and Caco-2 cells.
Topics: Animals; Anti-Inflammatory Agents; Caco-2 Cells; Colitis; Colon; Dextran Sulfate; Disease Models, Animal; Gastrointestinal Agents; Heterocyclic Compounds, 3-Ring; Humans; Indazoles; Inflammation Mediators; Intestinal Mucosa; Male; Mice, Inbred BALB C; Mitogen-Activated Protein Kinases; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Pyroptosis; Signal Transduction; Tight Junctions | 2019 |
Murine colitis treated with multitargeted tyrosine kinase inhibitors.
Topics: Animals; Axitinib; Colitis; Imidazoles; Indazoles; Indoles; Male; Mice; Mice, Inbred C57BL; Microvessels; Neovascularization, Pathologic; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Pyrroles; Sorafenib; Sunitinib; Treatment Outcome | 2016 |
Treatment with bindarit, an inhibitor of MCP-1 synthesis, protects mice against trinitrobenzene sulfonic acid-induced colitis.
Topics: Animals; Cells, Cultured; Chemokine CCL2; Colitis; Disease Progression; Epithelial Cells; Female; Humans; Indazoles; Interferon-gamma; Mice; Mice, Inbred BALB C; Propionates; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha | 2008 |